Who we are

Who we are

MISSION

Driven by Purpose, Focused on Patients

To build Exonol Pharmaceuticals into a brand deeply respected by patients and doctors globally, by delivering patient-focused, high-quality medicines to every corner of the world. We are dedicated to serving underserved communities with affordable treatments, ensuring un-compromised efficacy and rigorous sterile barrier systems to guarantee safety.

Vision

To emerge as a global leader by driving accessibility through technology-integrated solutions and relentless R&D, ensuring that innovation translates into quality and affordability for everyone, everywhere.

Vision

Redefining Healthcare Through Technology and Research

$28.90M
Assets under management
$6bn
Saved for clients annually
90%
Repeat clients or referrals
120+
Professionals
values

Built on Trust and Excellence

We offer a deeply personalized approach, providing objective, customized advice, seamless wealth management, and exclusive access to private investments, all designed to help clients reach their goals and build lasting wealth.

The Foundation of Trust

Rooted in Integrity and Ethics, we promise Reliability to our patients and partners. We believe that trust is earned through the Consistency of our actions and the quality of our products.

The Standard of Performance

We do not settle for average; we strive for Excellence in every aspect of our operations. We ensure that our quality remains high and our delivery remains dependable.

The Vision for Tomorrow

Healthcare is ever-evolving, and so are we. Through Innovation and Adaptability, we meet new challenges head-on, while practicing Sustainability to protect the communities and environment we serve.

Experienced

A highly dedicated team, supported by our extensive network of trusted professionals,

our history

Here's How We Got Started

2025

The Begining

In the complex language of human genetics, there is a distinct difference between potential and action. While DNA contains the vast library of our genetic makeup, it is the Exon that tells the story.

The Exon is the ‘coding region’ of the DNA strand. It is the active, functional sequence that remains after the non-essential parts are spliced away. The Exon is what expresses proteins; it is the biological engine that builds and sustains life.

At Exonol Pharmaceuticals, we derive our name from this fundamental biological truth. We believe in stripping away the non-essential to focus purely on efficacy and results. We view our medicines as the vital tools that help the human body function exactly as its healthiest genetic code intended.

Our Manufacturer

Windlas Biotech Limited

Windlas Biotech was born in year 2000. Over the past two decades, Windlas has evolved into a fully integrated partner providing products and services to leading pharmaceutical companies. – Some achievements –

2016 – Crossed Rs. 300 Cr. turnover.

2017 – Plant 3 set up completed. Launched 1st product in US from WHC

2018 – 23 Million Dollar investment from Zydus in WHC

2019 – Buyback of Zydus’ share in Windlas Healthcare

At Exonol, trust, performance, and future-readiness come together to create healthcare solutions that matter—today and tomorrow.

John Smith
John Smith

Redefining Pharmaceutical Care